Cantargia AB vs Oryzon Genomics SA
Oryzon Genomics SA is the older company (2010 vs 2000); Oryzon Genomics SA is the larger of the two.
Side-by-Side Comparison
| Metric | Cantargia AB | Oryzon Genomics SA |
|---|---|---|
| Founded | ||
| Founded | 2010 | 2000 older |
| Headquarters | ||
| Headquarters | Lund, Sweden | Spain |
| Employees | ||
| Employees | 32 | 60 larger |
| Industry | ||
| Industry | Biotechnology, Health and Wellness, Medical Devices | Not tracked yet |
| Funding Stage | ||
| Funding Stage | Post-IPO Equity | IPO |
| Total Funding | ||
| Total Funding | $257.00M | $193.19M |
| Funding Rounds | ||
| Funding Rounds | 2 | 21 |
| Services | ||
| Services | Not tracked yet | Development of personalized therapeutics, Epigenetic biomarker identification, Innovation in cancer and CNS disorder treatments, Patent portfolio management |
| Target Customers | ||
| Target Customers | Not tracked yet | Patients with cancer, Patients with CNS disorders, Healthcare providers, Biopharmaceutical investors |
| Taxonomy | ||
| Taxonomy | Antibody-based TherapiesClinical ProgramsIL1RAPCancer TreatmentAutoimmune DiseasesInflammatory Diseases +8 | Personalized MedicineEpigeneticsCNS DisordersOncologyBiopharmaceuticalsLSD1 Inhibitors +9 |
| Website | ||
| Website | cantargia.com | oryzon.com |
About Cantargia AB
Cantargia is a Swedish listed biotechnology company that focuses on developing antibody-based therapies targeting IL1RAP. The company's clinical programs include nadunolimab, which is currently in phase II development for the treatment of cancer, and CAN10 in phase I development for autoimmune/infla...
About Oryzon Genomics SA
Oryzon Genomics SA, founded in 2000 and headquartered in Spain, is a clinical stage biopharmaceutical leader in the development of epigenetics-based therapeutics, with an emphasis on personalized medicine for CNS disorders and oncology. Known for its slogan, "Pioneering personalized medicine in epig...
Also comparing in this category
Comparing more than these two?
Get Cantargia AB, Oryzon Genomics SA and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.
How does Cantargia AB compare?
A PDF of Cantargia AB and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Rival Readout
Comparing competitors? We do this properly.
10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.
Frequently Asked Questions
Compare Cantargia AB with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at Cantargia AB on 12 Sep 2024, and Oryzon Genomics SA on 26 Mar 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
